Soovu Wearable Pain Relief – A “Therable” for Chronic Pain Relief

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

January 12, 2021

Soovu ™ Wearable Pain Relief, is a unique “therable” (wearable medical device and app) to treat chronic pain.

In the U.S. more money is spent on pain treatments and lost productivity than diabetes, cancer and heart disease combined. Clearly opioids are not the answer, and recently the FDA required NSAIDs, like Aleve and Advil, to include heart attack and stroke warnings on their labels. According to Chuck Chabal, MD and Co-Founder of Soovu Labs, “In the COVID era, pain complaints are up by 50%, as are comorbidities of anxiety, stress and depression. The need for transformation in the management of pain has never been greater.”

With funding from the National Institutes of Health, Dr. Chabal and fellow researcher and Co-Founder Dr. Peter Dunbar developed a drug-free, wearable for on-the-go relief.  These doctors discovered that pulsing high levels of heat on the skin desensitized the “TRPV1” receptor, and in so doing provided immediate and long-lasting relief of chronic pain1. Published, independent clinical studies confirmed that Soovu significantly reduced chronic pain compared to a placebo device. The Soovu companion app provides digital coaching to reduce stress and anxiety associated with pain, and sends results to the cloud for machine learning for personalized treatments. The device and app uniquely address both physiological and psychological pathways to pain relief.

Soovu Labs is currently completing a round of funding to scale up production. With its launch of Soovu Wearable Pain Relief in fall 2021, the company is poised to reduce the pain of millions of Americans and increase the possibilities in their lives.

Soovu Labs, Inc. is on a mission to transform the treatment of chronic pain without drugs, invasive procedures or surgery.  Their first product, Soovu Wearable Pain Relief, will target treatment of chronic back and neck pain.


Soovu Wearable Pain Therapy is indicated to provide topical heating for the purpose of elevating tissue temperature for the temporary relief of minor muscle and joint pain and stiffness; the temporary relief of joint pain associated with arthritis; the temporary relief of muscle spasms, minor sprains and strains, and minor muscular back pain; the temporary relief of menstrual discomfort; the relaxation of muscles; and the temporary increase of local circulation where applied.

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.